JPMorgan analyst Stephen Tusa says Emerson Electric’s (EMR) "extended" $60 per share bid for National Instruments (NATI) is a "net negative" but does not change the stock’s attractive risk/reward based on valuation. The analyst likes the National Instruments asset and sees "material improvement opportunities," but says the purchase price is a "mathematical negative." Emerson shares are retesting lows, down 13% year-to-date, and are "cheap," the analyst tells investors in a research note. However, the firm struggles to find catalysts for a re-rating "after this type of stretch of capital deployment." It keeps a Neutral rating on Emerson Electric.
Elevate Your Investing Strategy:
- Take advantage of TipRanks Premium at 55% off! Unlock powerful investing tools, advanced data, and expert analyst insights to help you invest with confidence.
Published first on TheFly
See the top stocks recommended by analysts >>
Read More on EMR:
- Emerson went against word by buying NATI, says Deutsche Bank
- National Instruments downgraded to Equal Weight at Morgan Stanley
- Emerson (NYSE:EMR) Acquires National Instruments for $60 a Share
- Emerson Electric sees $165M of cost synergies by year 5 from NI acquisition
- Emerson Electric sees National Instruments acquisition ‘immediately accretive’